BRIEF-Allergan CEO says investors must question Valeant's "mishmash" financial reporting

June 10 Tue Jun 10, 2014 11:14am EDT

June 10 (Reuters) - Allergan: * Allergan CEO says he's an "endurance player," prepared for long

battle with Valeant * Allergan CEO says first priority among its shareholders is for company to

make strategic acquisitions * Allergan CEO says Valeant stands alone in industry by failure to disclose

product sales, instead has "mishmash" of reporting buckets * Allergan CEO says company, investors need to question value of Valeant stock

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.